Hosted on MSN49m
Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s WorrisomeGlucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, and have become wildly popular with the general population for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback